CAR-T transformed blood cancer care, but solid and brain tumors demand different delivery, manufacturing, and safety strategies to work.
|Articles|August 1, 2015
- BioPharm International-08-01-2015
- Volume 28
- Issue 8
BioPharm International, August 2015 Issue (PDF)
Click the title above to open the BioPharm International August 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Drug Delivery Systems for Biopharmaceuticalsover 11 years ago
Selecting a Comprehensive Bioburden Reduction Planover 11 years ago
Mastering Cell Bank Productionover 11 years ago
Campaign Against Fake Drugs Gains Momentumover 11 years ago
Outsourcing Becoming More Cost Competitiveover 11 years ago
Finding a Cure for Early Pipeline Failuresover 11 years ago
Cleaning of Dedicated Equipment: Why Validation is Neededover 11 years ago
Fluid Handling in Biopharma FacilitiesAdvertisement
Related to this article
AAPS PharmSci 360 2026 in New Orleans centered on auditable AI, modeling-guided formulation, oral peptide delivery, high-concentration antibody suspensions, and the push toward $10-per-gram monoclonal antibodies.
Samsung Biologics' pending PolyPeptide deal adds peptide API manufacturing, including GLP-1 supply, to its antibody and ADC CDMO services.
The deal gives Fresenius options on biosimilars spanning monoclonal and bispecific antibodies, ADCs, and fusion proteins, starting with polatuzumab vedotin and teprotumumab, and could expand its portfolio from 29 to 66 molecules.
FDA set a May 1, 2027 target date for AMT-130, a one-time gene therapy that silences the huntingtin gene, and plans an advisory committee meeting.
Inovio reports that Voceryq spared 27% of adults with recurrent respiratory papillomatosis from surgery for 12 months in a 26-patient efficacy group.
Three case studies show how automated Raman plate reading can triage samples before chromatography in bioprocess development.
This year’s AAPS PharmSci 360 highlighted AI transparency, computer modeling in formulation, oral peptide delivery, and new business models.
Advertisement
Advertisement
Trending on BioPharm International
1
Drug Digest: Reshoring Manufacturing and Securing Cold-Chain Supply for Biopharma
2
Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer
3
Fresenius and WuXi Biologics Sign Exclusive Agreement Covering Up to 37 Biosimilar Candidates
4
Resolving the Speed-Specificity Trade-Off in Biopharma High-Throughput Screening
5